Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-May-24 5:41 PM View:  | Haemonetics Corp. (HAE) | 17-May-24 | Grant | 4,439 | -- | -- | 34% 12.91K to 17.35K | |
| 17-May-24 4:52 PM View: | Haemonetics Corp. (HAE) | 16-May-24 | Payment of Exercise | 351 | $94.80 | $33,274.80 | (3%) 13.26K to 12.91K | |
| 17-May-24 4:52 PM View: | Haemonetics Corp. (HAE) | 15-May-24 | Payment of Exercise | 412 | $96.49 | $39,753.90 | (3%) 13.67K to 13.26K | |
| 06-May-24 4:19 PM View: | Haemonetics Corp. (HAE) | 02-May-24 | Payment of Exercise | 432 | $93.33 | $40,318.60 | (3%) 14.1K to 13.67K | |
| 03-Aug-23 2:01 PM View: | Prestige Brands Holdings Inc. (PBH) | 01-Aug-23 | Grant | 2,295 | -- | -- | 100% 0 to 2.29K | |
| 17-May-23 4:26 PM View: | Haemonetics Corp. (HAE) | 16-May-23 | Payment of Exercise | 349 | $89.21 | $31,134.30 | (2%) 14.45K to 14.1K | |
| 17-May-23 4:26 PM View: | Haemonetics Corp. (HAE) | 15-May-23 | Grant | 4,205 | -- | -- | 41% 10.25K to 14.45K | |
| 04-May-23 4:27 PM View: | Haemonetics Corp. (HAE) | 02-May-23 | Payment of Exercise | 430 | $81.66 | $35,113.80 | (4%) 10.68K to 10.25K | |
| 18-May-22 4:34 PM View: | Haemonetics Corp. (HAE) | 16-May-22 | Grant | 4,774 | -- | -- | 81% 5.9K to 10.68K | |
| 04-May-22 4:41 PM View: | Haemonetics Corp. (HAE) | 02-May-22 | Grant | 5,902 | -- | -- | 100% 0 to 5.9K | |
| 12-Aug-21 9:33 PM View: | Croff Enterprises Inc. (TXMD) | 12-Aug-21 | Market Option Sale | 93,337 | $0.87 | $81,203.20 | (43%) 217.17K to 123.83K | |
| 12-Aug-21 9:33 PM View: | Croff Enterprises Inc. (TXMD) | 10-Aug-21 | Option Exercise | 217,167 | -- | -- | 100% 0 to 217.17K | |
| 11-May-20 9:50 PM View: | Allergan Plc (AGN) | 08-May-20 | Disposition | 9,835 | -- | -- | (100%) 9.84K to 0 | |
| 10-Mar-20 2:10 PM View: | Allergan Plc (AGN) | 06-Mar-20 | Payment of Exercise | 718 | $191.95 | $137,820.00 | (7%) 10.55K to 9.83K | |
| 04-Mar-20 2:22 PM View: | Allergan Plc (AGN) | 02-Mar-20 | Grant | 3,611 | $193.84 | $699,956.00 | 52% 6.94K to 10.55K | |
| 02-Jan-20 5:52 PM View: | Allergan Plc (AGN) | 31-Dec-19 | Payment of Exercise | 92 | $191.17 | $17,587.60 | (1%) 7.03K to 6.94K | |
| 11-Mar-19 5:49 PM View: | Allergan Plc (AGN) | 08-Mar-19 | Payment of Exercise | 113 | $145.06 | $16,391.80 | (2%) 7.15K to 7.03K | (3%) |
| 11-Mar-19 5:49 PM View: | Allergan Plc (AGN) | 07-Mar-19 | Payment of Exercise | 359 | $143.00 | $51,337.00 | (5%) 7.5K to 7.15K | (5%) |
| 08-Mar-19 3:27 PM View: | Allergan Plc (AGN) | 06-Mar-19 | Grant | 2,036 | $137.51 | $279,970.00 | 37% 5.47K to 7.5K | 9% |
| 06-Mar-19 3:49 PM View: | Allergan Plc (AGN) | 04-Mar-19 | Payment of Exercise | 114 | $139.12 | $15,859.70 | (2%) 5.58K to 5.47K | (8%) |
| 03-Jan-19 3:50 PM View: | Allergan Plc (AGN) | 31-Dec-18 | Payment of Exercise | 147 | $133.66 | $19,648.00 | (3%) 5.6K to 5.45K | (13%) |
| 09-Mar-18 4:34 PM View: | Allergan Plc (AGN) | 08-Mar-18 | Payment of Exercise | 79 | $153.50 | $12,126.50 | (1%) 5.68K to 5.6K | 3% |
| 08-Mar-18 4:16 PM View: | Allergan Plc (AGN) | 07-Mar-18 | Grant | 1,696 | $153.22 | $259,861.00 | 42% 4.08K to 5.77K | (3%) |
| 08-Mar-18 4:16 PM View: | Allergan Plc (AGN) | 07-Mar-18 | Payment of Exercise | 93 | $153.22 | $14,249.50 | (2%) 5.77K to 5.68K | 3% |
| 06-Mar-18 6:53 PM View: | Allergan Plc (AGN) | 05-Mar-18 | Payment of Exercise | 70 | $148.73 | $10,411.10 | (2%) 4.15K to 4.08K | < 1% |
| 06-Mar-18 6:53 PM View: | Allergan Plc (AGN) | 02-Mar-18 | Payment of Exercise | 76 | $144.02 | $10,945.50 | (2%) 4.22K to 4.15K | (3%) |
| 02-Jan-18 4:40 PM View: | Allergan Plc (AGN) | 29-Dec-17 | Payment of Exercise | 100 | $163.58 | $16,358.00 | (2%) 4.32K to 4.22K | 10% |
| 30-Oct-17 9:19 PM View: | Allergan Plc (AGN) | 26-Oct-17 | Option Exercise | 799 | -- | -- | 23% 3.52K to 4.32K | |
| 09-Mar-17 5:53 PM View: | Allergan Plc (AGN) | 08-Mar-17 | Payment of Exercise | 77 | $239.44 | $18,436.90 | (2%) 3.6K to 3.52K | 39% |
| 09-Mar-17 5:53 PM View: | Allergan Plc (AGN) | 07-Mar-17 | Grant | 1,085 | $239.60 | $259,966.00 | 43% 2.52K to 3.6K | (39%) |
| 07-Mar-17 4:54 PM View: | Allergan Plc (AGN) | 05-Mar-17 | Payment of Exercise | 66 | $245.63 | $16,211.60 | (3%) 2.58K to 2.52K | 40% |
| 07-Mar-17 4:54 PM View: | Allergan Plc (AGN) | 04-Mar-17 | Payment of Exercise | 72 | $245.63 | $17,685.40 | (3%) 2.65K to 2.58K | 40% |
| 03-Feb-17 7:43 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Grant | 238 | $229.32 | $54,578.20 | 9% 2.51K to 2.75K | (36%) |
| 03-Feb-17 7:43 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Payment of Exercise | 92 | $229.32 | $21,097.40 | (3%) 2.75K to 2.65K | 36% |
| 12-May-16 5:53 PM View: | Allergan Plc (AGN) | 08-Mar-16 | Grant | 914 | $284.43 | $259,969.00 | 57% 1.59K to 2.51K | (49%) |
| 09-Mar-15 6:02 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Grant | 456 | -- | -- | 38% 1.22K to 1.67K | |
| 09-Mar-15 6:02 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Payment of Exercise | 78 | $295.70 | $23,064.60 | (5%) 1.67K to 1.59K | 51% |
| 06-Mar-15 5:55 PM View: | Allergan Plc (AGN) | 04-Mar-15 | Grant | 877 | $296.14 | $259,715.00 | 259% 0.34K to 1.22K | (51%) |
| 13-May-14 5:08 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 338 | $197.05 | $66,602.90 | 100% 0 to 0.34K | (26%) |